Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
FDA clearance for Echosens’ FibroScan non-invasive liver diagnostic tool marks the last major market approval for the device. The 510k clearance for Echosense marks the last major market to approve the FibroScan device. The Paris, France-based medical device company first introduced the FebroScan in Europe in 2003, and it has since won approvals in 70 countries.
Help employers find you! Check out all the jobs and post your resume.
FDA clearance for Echosens’ FibroScan non-invasive liver diagnostic tool marks the last major market approval for the device. The 510k clearance for Echosense marks the last major market to approve the FibroScan device. The Paris, France-based medical device company first introduced the FebroScan in Europe in 2003, and it has since won approvals in 70 countries.
Help employers find you! Check out all the jobs and post your resume.
